Atrial tachycardias in young adults and adolescents with congenital heart disease: Conversion using single dose oral sotalol

International Journal of Cardiology

Volumn 136, Issue 3, 2009, Pages 253-257

  Rao, Sri O ^a   Boramanand, Nicole K ^a,b   Burton, David A ^c   Perry, James C ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Children's Hospitals of Minnesota   (United States)

Author keywords

Adult congenital heart disease; Atrial flutter; Fontan; Sotalol

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; SOTALOL;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR SYNCHRONY LOSS; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FONTAN PROCEDURE; HEART ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; REENTRY TACHYCARDIA; SCHOOL CHILD; SINGLE DRUG DOSE; SINUS BRADYCARDIA; SINUS RHYTHM; SUPRAVENTRICULAR PREMATURE BEAT; THROMBOEMBOLISM; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; CHILD; HEART DEFECTS, CONGENITAL; HUMANS; PROSPECTIVE STUDIES; SOTALOL; TACHYCARDIA, ECTOPIC ATRIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68049084690     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.060     Document Type: Article

References (15)

1. Garson Jr. A., Bink-Boelkens M., Hesslein P.S., Hordof A.J., Keane J.F., Neches W.H., and Porter C.J. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 6 (1985) 871-878
2. Tanel R.E., Walsh E.P., Lulu J.A., and Saul J.P. Sotalol for refractory arrhythmias in pediatric and young adults: initial efficacy and long-term outcome. Am Heart J 130 (1995) 791-797
3. Maragnes P., Tipple M., and Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 69 (1992) 751-754
4. Pfammatter J.P., Saul T., Lehmann C., and Kallfelz H.C. Efficacy of proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 26 (1995) 1002-1007
5. Beaufort-Krol G.C.M., and Bink-Boelkens M. Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease. Am J Cardiol 79 (1997) 92-94
6. Chasen-Jaber L., and Stampfer M. Epidemiology of oral contraceptives and cardiovascular disease. Ann Int Med 6 (1998) 467-477
7. Saul J.P., Ross B., Schaffer M.S., Beerman L., Melikian A.P., Shi J., Williams J., Barbey J.T., Jin J., Hinderling P.H., and Pediatric Sotalol Investigators. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia. Clin Pharmacol Ther 69 (2001) 145-157
8. Saul J.P., Schaffer M.S., Karpawich P.P., Erickson C.C., Epstein M.R., Melikian A.P., Shi J., Karara A.H., Cai B., and Hinderling P.H. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia. J Clin Pharm 41 (2001) 35-43
9. Shi J., Ludden T.M., Melikian A.P., Gastonguay M.R., and Hinderling P.H. Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia. J Pharm 6 (2001) 555-575
10. Triedman J.K., Alexander M.E., Love B.A., Collins K.K., Berul C.I., Bevilacqua L.M., and Walsh E.P. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 39 (2002) 1827-1835
11. Gallagher M.M., Hennessy B.J., Edvardsson N., Hart C.M., Shannon M.S., Obel O.A., Al-Saady N.M., and Camm A.J. Embolic complications of direct current cardioversion of atrial arrhythmias: association of low intensity of anticoagulation at time of conversion. J Am Coll Cardiol 40 (2002) 926-933
12. Fatkin D., Kuchar D.L., Thorburn C.W., and Feneley M.P. Transesolphageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence of "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 23 (1994) 307-316
13. Hoyer A.W., and Balaji s. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol 30 (2007) 1003-1008
14. Hongo R.H., Themistoclakis S., Raviele A., Bonso A., Rosillo A., Glatter K.A., Yang Y., and Scheinman M.M. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. J Am Coll Cardiol 44 (2004) 864-868
15. Fish F.A., Gillette P.C., and Benson Jr. D.W. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 18 (1991) 356-365